Publication | Open Access
AR420626, a selective agonist of GPR41/FFA3, suppresses growth of hepatocellular carcinoma cells by inducing apoptosis <i>via</i> HDAC inhibition
41
Citations
26
References
2020
Year
AR420626, a selective GPR41/FFA3 agonist, may be a candidate as a therapeutic agent for HCC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1